All Pharma News
price-trendAsk Us
Medeor Therapeutics Announces Interim Data from Pivotal Trial Showing Cell Therapy Technology Could Eliminate Life-Long Need for Immunosuppressant Drugs Following Kidney Transplant

Medeor Therapeutics Announces Interim Data from Pivotal Trial Showing Cell Therapy Technology Could Eliminate Life-Long Need for Immunosuppressant Drugs Following Kidney Transplant
BUSINESSWIRE
02 Nov 2023
Share Share
Medeor’s cell therapy boosts immune tolerance in registrational trial

Medeor’s cell therapy boosts immune tolerance in registrational trial
Ayisha Sharma ENDPTS
02 Nov 2023
Share Share
Cell therapy allows kidney recipients to cut immunosuppressants

Cell therapy allows kidney recipients to cut immunosuppressants
Annalee Armstrong FIERCE BIOTECH
02 Nov 2023
Share Share
Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101

Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101
BUSINESSWIRE
20 May 2021
Share Share
Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101

Medeor Therapeutics to Provide Interim Results of Ph3 Mercury Study of MDR-101
BUSINESSWIRE
20 May 2021
Share Share
Medeor Completes Enrollment and Transplantation for Pivotal Trial of MDR-101

Medeor Completes Enrollment and Transplantation for Pivotal Trial of MDR-101
BUSINESSWIRE
12 May 2021
Share Share
Medeor Completes Enrollment & Transplantation for Pivotal Trial of MDR-101

Medeor Completes Enrollment & Transplantation for Pivotal Trial of MDR-101
BIOSPACE
12 May 2021
Share Share